Literature DB >> 25014640

The synthesis and biological evaluation of new DNA-directed alkylating agents, phenyl N-mustard-4-anilinoquinoline conjugates containing a urea linker.

Bhavin Marvania1, Rajesh Kakadiya1, Wilson Christian1, Tai-Lin Chen2, Ming-Hsi Wu2, Sharda Suman2, Kiran Tala2, Te-Chang Lee3, Anamik Shah4, Tsann-Long Su5.   

Abstract

We synthesized a series of phenyl N-mustard-4-anilinoquinoline conjugates to study their antitumorigenic effects. These agents were prepared by the condensation of 4-[N,N-bis(2-chloroethyl)amino]phenyl isocyanate with 6-amino-4-methylamino or 4-anilinoquinolines. The structure-activity relationship (SAR) studies revealed that the C2-methylquinoline derivatives (18a-o) were generally more cytotoxic than the C2-phenylquinoline conjugates (23a-d) in inhibiting the cell growth of various human tumor cell lines in vitro. However, the methylamino or aniline substituents at C4 of quinoline did not influence the cytotoxic effects. The title conjugates were capable of inducing DNA cross-linking and promoting cell-cycle arrest at the G2/M phase. This study demonstrates that phenyl N-mustard-4-anilinoquinoline conjugates are generally more potent than phenyl N-mustard-4-anilinoquinazoline conjugates against the cell growth of various tumor cell-lines.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cell cycle; DNA cross-linking; DNA-directed alkylating agents; Phenyl N-mustard; Quinolines

Mesh:

Substances:

Year:  2014        PMID: 25014640     DOI: 10.1016/j.ejmech.2014.06.066

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  1 in total

1.  Design and synthesis of novel hydroxyanthraquinone nitrogen mustard derivatives as potential anticancer agents via a bioisostere approach.

Authors:  Li-Ming Zhao; Feng-Yan Ma; Hai-Shan Jin; Shilong Zheng; Qiu Zhong; Guangdi Wang
Journal:  Eur J Med Chem       Date:  2015-08-06       Impact factor: 6.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.